Search for: "Becton, Dickinson " Results 321 - 340 of 446
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Nov 2010, 1:11 am by Kelly
Becton-Dickinson (Patent Docs) US government intervenes in patentability of genes – AMP v USPTO (Patent Baristas) (Holman’s Biotech IP Blog) (Intellectual Property Law Blog) (Inovia) (BlawgIT) (IP Osgoode) US: BIO and AUTM fire back at gene patent foes – AMP v USPTO (Patent Baristas) (Patent Docs) US: IPO files amicus brief in AMP v USPTO (Patent Docs) (Patent Baristas) US: AIPLA submits amicus brief in AMP v USPTO (Patent Docs) US: Summary of Myriad patent claims… [read post]
9 Nov 2010, 3:09 pm
Becton Dickinson Vascular Access, Inc., 120 F.3d 1253, 1256 (Fed. [read post]
9 Nov 2010, 10:33 am by Lawrence B. Ebert
Becton Dickinson Vascular Access, Inc., 120 F.3d 1253, 1256 (Fed. [read post]
8 Nov 2010, 9:59 pm by Patent Docs
Becton, Dickinson & Co., and it is timely to discuss this brief on the eve of oral argument before the en banc Federal Circuit. [read post]
8 Nov 2010, 10:01 am by Matt Osenga
Becton Dickinson This case will be heard by the 9 active judges plus Senior Judge Daniel Friedman. [read post]
5 Nov 2010, 9:59 pm by Patent Docs
The Catholic University of America Columbus School of Law and Federal Circuit Bar Association Charitable and Educational Fund will be holding a panel discussion entitled "The Ethical Ramofications of Therasense" from 4:00 pm to 5:30 pm (EST) on November 9, 2010. [read post]
3 Nov 2010, 1:21 am by Kelly
No – discussion of patent-eligibility standards for genes (Patent Baristas) US: Appellees file reply brief in Therasense v Becton Dickinson (Patent Docs) US: Another Capitol Hill missive objects to the inclusion of patent settlement provisions in FY 2011 Appropriations Bill (FDA Law Blog) US: REMS and 180-day exclusivity forfeiture – some interesting disclosures to the SEC (FDA Law Blog) Products Botox (Botulinum) – EU: General Court upholds opposition to BOTUMAX… [read post]
27 Oct 2010, 3:38 am by Kelly
General GSK forms alliance for development of gene therapy techniques for rare diseases (Patent Docs) Emerging economies’ new initiative on falsified and substandard medicines (IP Watch) Michèle Rivasi asks question about ACTA and Access to Medicine (KEI) As negotiators launch talks on biodiversity, industry requests IP protection (IP Watch) Negotiators persist on biodiversity benefit-sharing treaty despite slipping deadlines (IP Watch) New draft biodiversity treaty text shows much work… [read post]
22 Aug 2010, 9:59 pm by Patent Docs
Becton, Dickinson & Co. bring this quote to mind, since none of them advocate that the Federal Circuit's inequitable conduct jurisprudence is anything other than dysfunctional. [read post]
19 Aug 2010, 9:59 pm by Patent Docs
Becton, Dickinson & Co. have mentioned (if not bemoaned) the negative effects the Federal Circuit's inequitable conduct jurisprudence has had on the functioning of the U.S. [read post]
16 Aug 2010, 10:27 pm by Patent Docs
Becton, Dickinson & Co. case, in support of neither party but arguing forcefully that the current state of the Federal Circuit's jurisprudence on inequitable conduct is in need of correction. [read post]
10 Aug 2010, 8:44 pm by Marie Louise
  General Coverage of anti-counterfeit policy debate varies widely across global media (IP Watch) WHO declares flu pandemic over; experts behind response to be revealed (IP Watch) Australia: TGA to implement alert system for new ARTG registrations (IP Whiteboard) EU: Final petition of the Advocate-General / Jodosulfuron- SPC for plant protection products (EPLAW) India: Parliamentary Committee on Health tables report on issues relating to availability of generic medicines (Spicy IP) Peru:… [read post]